Patents by Inventor Rudi Baron

Rudi Baron has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhibitors of isoprenylcysteine carboxyl methyltransferase
    Patent number: 7964629
    Abstract: The present invention relates, in general, to isoprenylcysteine carboxyl methyltransferase (Icmt) and, in particular, to inhibitors of Icmt and to methods of disease treatment using same.
    Type: Grant
    Filed: March 20, 2006
    Date of Patent: June 21, 2011
    Assignee: Duke Universtiy
    Inventors: Patrick J. Casey, Rudi A. Baron, Ann M. Winter-Vann
  • Inhibitors of Isoprenylcysteine Carboxyl Methyltransferase
    Publication number: 20080171782
    Abstract: The present invention relates, in general, to isoprenylcysteine carboxylmethyltransferase (Icmt) and, in particular, to inhibitors of Icmt and to methods of disease treatment using same.
    Type: Application
    Filed: March 20, 2006
    Publication date: July 17, 2008
    Inventors: Patrick J. Casey, Rudi Baron, Ann Winter-Vann
  • Biotin derivatives, methods for making same and uses thereof as vectors
    Publication number: 20040138446
    Abstract: The invention concerns biotin derivatives of general formula (I), wherein: R1 represents a specific compound; X1 represents a carbonaceous chain, preferably of 1 to 10 carbon atoms, substituted or not, optionally comprising one or several carbonyl or oxycarbonyl groups, and/or a —NH— group, in particular a chain of formula —HN(CH2)n—O—CO wherein n is an integer between 1 and 5 and optionally comprising one or several ether, amide and/or amino functions; Y represents a hydrocarbon chain of 1 to 5 carbon atoms, substituted or not; R2 represents a hydrogen atom, or a protecting group, in particular R2 represents an alkyl group of 1 to 5 carbon atoms. The invention is useful as vectors, in particular for implementing methods for detecting interactions between biological compounds, and in pharmaceutical compositions.
    Type: Application
    Filed: December 9, 2003
    Publication date: July 15, 2004
    Inventors: Abdelakim Kharrat, Khalil Bouayadi, Jean-Charles Faye, Emmanuelle Fourcade, Rudi Baron, Daniel Tovar, Casimir Blonski